NCT07244445Recruiting
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
Dietary Pistachio Intake and Nutrition-Related Outcomes in Individuals Using GLP-1 Receptor Agonists: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
In this study will look at how eating pistachios every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding pistachios to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating pistachios improves overall diet quality and health markers like tiredness and certain levels in blood.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- 29 Jan 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Ian J. Neeland, MD
- Diseases
- Obesity
- NCT number
- NCT07244445
What you commit to
- Study type: Interventional
- Planned participants: 108
- From 29 Jan 2026 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known allergy to nuts
Other
- No use or contraindication to use of a GLP-1 RA
- Pregnant or breastfeeding
- Incarcerated
Who the study is looking for
- Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been continuously using semaglutide or tirzepatide for three months for a clinical indication and remain on the therapy at the time of enrollment
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospitals Cleveland Medical Center Coordinator of this site? Confirm its status | Clevland | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.